Cargando…

Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast

Invasive lobular carcinoma (ILC) accounts for approximately 10% of all breast carcinomas and is characterized by higher levels of androgen receptor (AR) compared to invasive ductal carcinoma (IDC). Despite this potentially androgen-responsive environment, the combined importance of AR and androgen m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoda, Tomomi, McNamara, Keely May, Miki, Yasuhiro, Takagi, Mayu, Rai, Yoshiaki, Ohi, Yasuyo, Sagara, Yasuaki, Tamaki, Kentaro, Hirakawa, Hisashi, Ishida, Takanori, Suzuki, Takashi, Ohuchi, Noriaki, Sasano, Hironobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462384/ https://www.ncbi.nlm.nih.gov/pubmed/25230018 http://dx.doi.org/10.1111/cas.12535

Ejemplares similares

ODP559 The prognostic role of IL-17A-neutrophils crosstalk in triple-negative breast cancer
por: Khalid, Freeha, et al.
Publicado: (2022)

Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment
por: Sakurai, Minako, et al.
Publicado: (2017)

Phase Two Steroid Metabolism and Its Roles in Breast and Prostate Cancer Patients
por: McNamara, Keely M., et al.
Publicado: (2013)

Prognostic significance of tumor-infiltrating CD8(+) and FOXP3(+) lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
por: Miyashita, Minoru, et al.
Publicado: (2015)

Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment
por: Takagi, K, et al.
Publicado: (2013)

An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma
por: Masuda, Mariko, et al.
Publicado: (2012)

Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer
por: Umekita, Yoshihisa, et al.
Publicado: (2011)

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway in Breast Cancer
por: Iwabuchi, Erina, et al.
Publicado: (2021)

Mucocele-like lesions of the breast: a long-term follow-up study
por: Ohi, Yasuyo, et al.
Publicado: (2011)

Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
por: Hida, Akira I., et al.
Publicado: (2016)

ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens
por: Takagi, Kiyoshi, et al.
Publicado: (2018)

The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer
por: Forsare, Carina, et al.
Publicado: (2022)

Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers
por: Ulm, Michael, et al.
Publicado: (2019)

Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity
por: Hong, Yanyan, et al.
Publicado: (2009)

Quantitative diagnosis of HER2 protein expressing breast cancer by single‐particle quantum dot imaging
por: Miyashita, Minoru, et al.
Publicado: (2016)

Retinoic Acid Receptor and Retinoid × Receptor in Ductal Carcinoma in situ and Intraductal Proliferative Lesions of the Human Breast
por: Ariga, Naohiro, et al.
Publicado: (2000)

Immunohistochemical analysis of insulin-like growth factor 1 and its receptor in sporadic schwannoma/peripheral nerve sheath tumour
por: Matsubara, Fumiaki, et al.
Publicado: (2016)

Clinical Significance of Occult Micrometastases in Axillary Lymph Nodes in “Node‐negative” Breast Cancer Patients
por: Umekita, Yoshihisa, et al.
Publicado: (2002)

In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics
por: McNamara, Keely M, et al.
Publicado: (2018)

TACC2 (transforming acidic coiled‐coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation
por: Onodera, Yoshiaki, et al.
Publicado: (2016)

Progesterone Receptor A and B Isoforms in the Human Breast and Its Disorders
por: Ariga, Naohiro, et al.
Publicado: (2001)

Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor
por: Verma, Mohit K, et al.
Publicado: (2013)

Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells
por: Yamaguchi, Mio, et al.
Publicado: (2021)

Evaluation of RASSF1A methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: A diagnostic accuracy study
por: Park, Sung Ae, et al.
Publicado: (2023)

Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus
por: Ishida, Hirotaka, et al.
Publicado: (2015)

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway
por: Iwabuchi, Erina, et al.
Publicado: (2021)

ODP562 ZnT5 Involvement in EMT in Breast Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2022)

GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor
por: Takagi, Kiyoshi, et al.
Publicado: (2014)

ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers
por: Miki, Yasuhiro, et al.
Publicado: (2022)

In Situ Evaluation of Estrogen Receptor Dimers in Breast Carcinoma Cells: Visualization of Protein-Protein Interactions
por: Iwabuchi, Erina, et al.
Publicado: (2017)

HIF-1α stimulates aromatase expression driven by prostaglandin E(2 )in breast adipose stroma
por: Samarajeewa, Nirukshi U, et al.
Publicado: (2013)

OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor‐positive breast carcinoma
por: Mayama, Akifumi, et al.
Publicado: (2018)

Microtubule-Associated Protein 2 as a DHEA Binding Protein in Endometrial Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2021)

Abnormal expression of miR‐1 in breast carcinoma as a potent prognostic factor
por: Minemura, Hiroyuki, et al.
Publicado: (2015)

CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance
por: Minemura, Hiroyuki, et al.
Publicado: (2016)

Forkhead Box I1 in Breast Carcinoma as a Potent Prognostic Factor
por: Onodera, Yoshiaki, et al.
Publicado: (2021)

c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target
por: Ozawa, Yohei, et al.
Publicado: (2015)

Aromatase in human liver and its diseases
por: Hata, Shuko, et al.
Publicado: (2013)

ODP543 Chemotherapy-induced extracellular HSP70 enhances pro-tumorigenic effects of macrophages in breast cancers.
por: Yamaguchi, Mio, et al.
Publicado: (2022)

Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis
por: Chishiki, Mayuko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vaet9ise4d211170grt5117rdv